NCT00732992
- Conditions
- Neoplasm, Malignant, Neoplasms
- Locations
-
- Pfizer Investigational Site Osakasayama-shi, Osaka, Japan
Clinical trial condition
Explore clinical trials studying Neoplasm, Malignant. Study availability and eligibility vary by location and protocol.
NCT00732992